TSA vs RSA in Glenohumeral Osteoarthritis (NCT04228419) | Clinical Trial Compass
RecruitingNot Applicable
TSA vs RSA in Glenohumeral Osteoarthritis
Canada108 participantsStarted 2020-03-09
Plain-language summary
This study will compare total shoulder arthroplasty (TSA) reverse shoulder arthroplasty (RSA) procedures, in the context of a prospective, randomized-controlled trial to determine the optimal treatment in patients 65 years of age and older, and equal to or less than 15 degrees of glenoid retroversion, who have glenohumeral osteoarthritis.
Who can participate
Age range65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Patients who have failed standard non-surgical management of their idiopathic shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as:
✓. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
✓. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
✓. Activity modification
✓. Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
✓. Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
✓. 65 years of age and older
Exclusion criteria
✕. Active joint or systemic infection
✕. Rotator cuff arthropathy
✕. Significant muscle paralysis
✕. Charcot's arthropathy
✕. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
✕. Unable to understand the consent form/process
What they're measuring
1
Western Ontario Osteoarthritis of the Shoulder Index (WOOS)